Inclusion Criteria:  Eastern Cooperative Oncology Group (ECOG) performance status grade of 0 or 1 Cardiac parameters within the specified range Women of childbearing potential must agree to all of the following during the study and for 3 months after the last dose of study drug: a) use a barrier method of contraception; b) use a highly effective contraceptive methods; c) not to donate eggs (ova, oocytes) or freeze them for future use for the purposes of assisted reproduction during the study; d) not to plan to become pregnant; e) not to breast-feed Willing and able to adhere to the lifestyle restrictions specified in this protocol Participants must have tumor tissue availability Adequate organ functions  Exclusion Criteria:  Known (active) Central Nervous System (CNS) involvement Prior treatment with JNJ-67856633 or another MALT1 inhibitor that is associated with disease progression or intolerable toxicities